Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Incyte Corporation - Common Stock (NQ:INCY)

109.57 -1.79 (-1.61%)
Delayed Quote Updated: 9:45 AM EDT, Oct 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Incyte Corporation - Common Stock

< Previous 1 2
...
12 13 14 15 16 17 18 19 20
...
29 30 Next >
News headline image
Incyte Reports 2024 Second Quarter Financial Results and Provides Updates on Key Clinical Programs
From Incyte
Via Business Wire
News headline image
Analyst Ratings For Incyte ↗
 
Via Benzinga
News headline image
Looking for growth without the hefty price tag? Consider NASDAQ:INCY. ↗
INCYTE CORP (NASDAQ:INCY) is showing decent growth, but is still valued reasonably. 
Via Chartmill
News headline image
NASDAQ:INCY is a prime example of a stock that offers more than what meets the eye in terms of fundamentals. ↗
INCYTE CORP (NASDAQ:INCY), an undervalued stock with good fundamentals. 
Via Chartmill
News headline image
S&P 500 Hits Record Highs, Eyes 6th Straight Gain As Powell Keeps Bears At Bay; Tesla Targets 10th Consecutive Win, Bank Stocks Rally: What's Driving Markets Tuesday? ↗
The S&P 500 index climbed to new all-time highs, rising 0.3% during Tuesday’s session, aiming for a potential sixth consecutive positive close and remaining resilient after Fed Chair Jerome Powell‘s... 
Via Benzinga
Topics Economy Stocks
News headline image
NASDAQ:INCY is not too expensive for the growth it is showing. ↗
In the world of growth stocks, INCYTE CORP (NASDAQ:INCY) shines as a value proposition. 
Via Chartmill
News headline image
Analyst Expectations For Incyte's Future ↗
 
Via Benzinga
News headline image
Incyte to Report Second Quarter Financial Results
From Incyte
Via Business Wire
News headline image
The 3 Most Undervalued Cathie Wood Stocks to Buy in July 2024 ↗
The stock market watches this investing guru's picks closely but these may be the best undervalued Cathie Wood stocks in her ETFs. 
Via InvestorPlace
News headline image
7 Cheap Biotech Stocks With Major Upside Potential ↗
While the broader healthcare sector enjoys permanent relevance, you can potentially maximize your upside with cheap biotech stocks. 
Via InvestorPlace
News headline image
Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Incyte
Via Business Wire
News headline image
Despite its growth, NASDAQ:INCY remains within the realm of affordability. ↗
Don't overlook INCYTE CORP (NASDAQ:INCY)—a stock with solid growth prospects and a reasonable valuation. 
Via Chartmill
News headline image
9 Analysts Have This To Say About Incyte ↗
 
Via Benzinga
News headline image
NASDAQ:INCY is showing decent growth, but is still valued reasonably. ↗
INCYTE CORP (NASDAQ:INCY) is not too expensive for the growth it is showing. 
Via Chartmill
News headline image
3 Highly Rated Biotech Stocks for Your July Buy List ↗
Discover three top-rated biotech stocks that are pushing forward the pharma and biotech revolution on Wall Street. 
Via InvestorPlace
News headline image
This CrowdStrike Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday ↗
 
Via Benzinga
News headline image
Stocks Chop As Wall Street Unpacks Powell Comments ↗
Stocks are mixed at midday, as investors weigh remarks from Federal Reserve Chair Jerome Powell. 
Via Talk Markets
Topics Economy
News headline image
7 Undervalued Biotech Stocks to Buy for Big-Time Returns ↗
The broader healthcare sector enjoys a powerfully relevant narrative. Undervalued biotech stocks makes the case even more attractive. 
Via InvestorPlace
News headline image
For those who appreciate value investing, NASDAQ:INCY is a compelling option with its solid fundamentals. ↗
In a market where value is scarce, INCYTE CORP (NASDAQ:INCY) offers a refreshing opportunity with its solid fundamentals. 
Via Chartmill
News headline image
Nasdaq 100, S&P 500 Close At Record Highs As Tech Stocks Reclaim Dominance: Thursday's Gainers & Losers ↗
The Nasdaq 100 index posted its fourth consecutive session in the green on Thursday, closing at 19,576 points and reaching all-time highs. 
Via Benzinga
Topics Stocks
News headline image
Incyte Announces Final Results of Tender Offer
From Incyte Corporation
Via Business Wire
News headline image
Incyte Announces Preliminary Results of Tender Offer
From Incyte Corporation
Via Business Wire
News headline image
Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Incyte
Via Business Wire
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
Incyte Completes Acquisition of Escient Pharmaceuticals
From Incyte
Via Business Wire
News headline image
When you look at NASDAQ:INCY, it's hard to ignore the strong fundamentals, especially considering its likely undervaluation. ↗
INCYTE CORP (NASDAQ:INCY) is a prime example of a stock that offers more than what meets the eye in terms of fundamentals. 
Via Chartmill
News headline image
Hedge Funds Tweak Portfolios In Q1: Marvell, TD Synnex, AES Get More Love As Focus Shifts To AI ↗
Hedge funds are looking for high-return opportunities beyond the mega-cap tech giants preferring to focus on cyclical sectors and AI. 
Via Benzinga
News headline image
Incyte Expands Presence in Delaware through Acquisition of Two Downtown Wilmington Office Buildings
From Incyte
Via Business Wire
News headline image
Incyte to Present at Upcoming Investor Conference
From Incyte
Via Business Wire
News headline image
Incyte to Highlight Data From its Oncology Portfolio at the 2024 ASCO Annual Meeting and EHA2024 Congress
From Incyte
Via Business Wire
< Previous 1 2
...
12 13 14 15 16 17 18 19 20
...
29 30 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.